Delayed Prostate Cancer Therapy Spring Valley NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

Norman Lester Rosen
(914) 965-2060
3333 Henry Hudson Way
Bronx, NY
SAMIR PAREKH, MD
(718) 920-4057
111 East 210Th Street
Bronx, NY
MICHELLE BOYAR, MD
(646) 227-3813
777 N Broadway
Tarrytown, NY
Sarada M Reddy, MD
201-967-4132
14 Skytop Rdg
Oakland, NJ
Louise G Ligresti, MD
914-368-3115
36 Oxford Dr
Montebello, NY
Mei Zhang
(201) 894-3125
350 Engle St
Englewood, NJ
Steven Edward Vogl
(718) 519-7774
2220 Tiemann Ave
Bronx, NY
JULIE GOLD, MD
(914) 241-1050
90 South Bedford Road
Mount Kisco, NY
Mark Anthony Ramirez, MD
718-405-1700
60 E 208th St
Bronx, NY
Alan D Steinfeld, MD
914-472-3276
82 Carthage Rd
Scarsdale, NY
Data Provided by:
      

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Hormone Therapy for Breast Cancer Spring Valley NY
Breast tenderness in women taking estrogen/progestin hormone replacement therapy could signal increased chances of developing breast cancer, a new study says. Women taking estrogen plus progestin who reported developing breast tenderness after starting the hormone therapy were 48 percent more likely to develop invasive breast cancer than women on hormone therapy who did not experience breast tenderness.
- Diagnosis of Prostate Cancer Spring Valley NY
- Attack Of The Cancer Fighting Tomatoes Spring Valley NY
- Hormone Therapy for Early Prostate Cancer Spring Valley NY
- Hormone Therapy for Prostate Cancer Spring Valley NY
- Drug Combo Proves Powerful Against Lung Cancer Spring Valley NY
- Head and Neck Cancer Treatment Spring Valley NY
- Hormone Therapy for Lung Cancer Spring Valley NY
- Open Prostatectomy Versus Laparoscopic Procedure Spring Valley NY
- Exercise for Prostate Cancer Spring Valley NY